Frontiers in Neuroscience (Jan 2020)

Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer’s Disease

  • Emilio Llanos-González,
  • Emilio Llanos-González,
  • Ángel Andres Henares-Chavarino,
  • Cristina María Pedrero-Prieto,
  • Cristina María Pedrero-Prieto,
  • Sonia García-Carpintero,
  • Sonia García-Carpintero,
  • Javier Frontiñán-Rubio,
  • Javier Frontiñán-Rubio,
  • Francisco Javier Sancho-Bielsa,
  • Francisco Javier Sancho-Bielsa,
  • Francisco Javier Alcain,
  • Francisco Javier Alcain,
  • Juan Ramón Peinado,
  • Juan Ramón Peinado,
  • Yoana Rabanal-Ruíz,
  • Yoana Rabanal-Ruíz,
  • Mario Durán-Prado,
  • Mario Durán-Prado

DOI
https://doi.org/10.3389/fnins.2019.01444
Journal volume & issue
Vol. 13

Abstract

Read online

Although the basis of Alzheimer’s disease (AD) etiology remains unknown, oxidative stress (OS) has been recognized as a prodromal factor associated to its progression. OS refers to an imbalance between oxidant and antioxidant systems, which usually consist in an overproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) which overwhelms the intrinsic antioxidant defenses. Due to this increased production of ROS and RNS, several biological functions such as glucose metabolism or synaptic activity are impaired. In AD, growing evidence links the ROS-mediated damages with molecular targets including mitochondrial dynamics and function, protein quality control system, and autophagic pathways, affecting the proteostasis balance. In this scenario, OS should be considered as not only a major feature in the pathophysiology of AD but also a potential target to combat the progression of the disease. In this review, we will discuss the role of OS in mitochondrial dysfunction, protein quality control systems, and autophagy associated to AD and suggest innovative therapeutic strategies based on a better understanding of the role of OS and proteostasis.

Keywords